Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Michael Shepard

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|September 18, 2015
Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer TherapyH Michael Shepard
Cell|September 15, 2019
The Team that Just Wouldn't Quit and a New Paradigm in Cancer Drug DiscoveryH Michael Shepard
Cancer Cell|April 3, 2026
Reactivating p53 mutants selectively in patientsShuo Chen, H Michael Shepard, Min Lu
The Journal of Clinical Investigation|November 5, 2008
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR familyH Michael Shepard, Cathleen M Brdlik, Hans Schreiber
Expert Opinion on Biological Therapy|December 10, 2008
A pan-HER approach for cancer therapy: background, current status and future developmentZhongdong Huang, Cathleen Brdlik, Pei Jin, et al.
Clinical Medicine (London, England)|June 3, 2017
Developments in therapy with monoclonal antibodies and related proteinsH Michael Shepard, Gail Lewis Phillips, Christopher D Thanos, et al.
Cancers|November 12, 2013
Therapeutic targeting of hyaluronan in the tumor stromaAnne Kultti, Xiaoming Li, Ping Jiang, et al.
Glycobiology|July 15, 2018
KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesionsMathieu Marella, Laurence Jadin, Gilbert A Keller, et al.
Arthritis Research & Therapy|October 11, 2011
Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockadeLuke L Gompels, Nasser M Malik, Leigh Madden, et al.
Arthritis and Rheumatism|September 30, 2008
Antagonism of the human epidermal growth factor receptor family controls disease severity in murine collagen-induced arthritisPercy F Sumariwalla, Pei Jin, Juan Zhang, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|September 18, 2015
Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer TherapyH Michael Shepard
Cell|September 15, 2019
The Team that Just Wouldn't Quit and a New Paradigm in Cancer Drug DiscoveryH Michael Shepard
Cancer Cell|April 3, 2026
Reactivating p53 mutants selectively in patientsShuo Chen, H Michael Shepard, Min Lu
The Journal of Clinical Investigation|November 5, 2008
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR familyH Michael Shepard, Cathleen M Brdlik, Hans Schreiber
Expert Opinion on Biological Therapy|December 10, 2008
A pan-HER approach for cancer therapy: background, current status and future developmentZhongdong Huang, Cathleen Brdlik, Pei Jin, et al.
Clinical Medicine (London, England)|June 3, 2017
Developments in therapy with monoclonal antibodies and related proteinsH Michael Shepard, Gail Lewis Phillips, Christopher D Thanos, et al.
Cancers|November 12, 2013
Therapeutic targeting of hyaluronan in the tumor stromaAnne Kultti, Xiaoming Li, Ping Jiang, et al.
Glycobiology|July 15, 2018
KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesionsMathieu Marella, Laurence Jadin, Gilbert A Keller, et al.
Arthritis Research & Therapy|October 11, 2011
Human epidermal growth factor receptor bispecific ligand trap RB200: abrogation of collagen-induced arthritis in combination with tumour necrosis factor blockadeLuke L Gompels, Nasser M Malik, Leigh Madden, et al.
Arthritis and Rheumatism|September 30, 2008
Antagonism of the human epidermal growth factor receptor family controls disease severity in murine collagen-induced arthritisPercy F Sumariwalla, Pei Jin, Juan Zhang, et al.
Pageof 4